Bell John K 4
4 · DelMar Pharmaceuticals, Inc. · Filed Sep 16, 2019
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Purchase
Common Stock
2019-09-13$0.68/sh+35,000$23,744→ 44,701 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.68 per share, inclusive. The reporting person undertakes to provide to DelMar Pharmaceuticals, Inc., any security holder of DelMar Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.